The Baltimore-based Esophageal Cancer Action Network (ECAN) has appointed Dr. Blair Jobe to its board of directors.
“This appointment to the Esophageal Cancer Action Network is an honor and a privilege,” said esophageal surgeon Dr. Blair Jobe. “I look forward to the opportunity to join forces with my fellow board members to carry out the organization’s mission to prevent, detect, treat and cure esophageal cancer.”
Dr. Jobe is a nationally renowned pioneer in the field of minimally invasive surgery and endoscopic therapy for the treatment of esophageal cancer, Barrett's esophagus, esophageal mobility disorders and gastroesophageal reflux disease (GERD). A prolific medical researcher and international lecturer, Dr. Jobe serves as the principal investigator for two National Institutes of Health (NIH) grants that focus on improving early detection of esophageal cancer, specifically on the development of serum and tissue biomarkers, a precursor to a blood test for the early detection and treatment of esophageal cancer.
In 2015, Dr. Jobe received Pittsburgh Business Times' Health Care Heroes award in the Health Care Innovation – Individual category for his discovery of four protein biomarkers which resulted in highly accurate and inexpensive findings in determining whether or not cancer was present.
“ACMH congratulates Dr. Jobe on his recent appointment to the ECAN board of directors,” said John Lewis, President and CEO of ACMH Hospital. “It is gratifying to know that a skilled surgeon who practices here at ACMH is counted amongst some of the most influential physicians across the country. When we welcomed Dr. Jobe to ACMH Hospital in 2015, he brought with him a wealth of information, skill and expertise. We are pleased to know that his presence will be enriching an even wider audience through his involvement with ECAN.”
ECAN’s mission is to save lives by increasing awareness about the link between heartburn and cancer, promoting early detection, supporting medical innovation to combat and cure esophageal cancer and link patients and families to compassionate support. This national non-profit organization –founded in 2009 – is led by a board of directors of top physicians, business leaders, and families that have been touched by esophageal cancer.
To effectively fight esophageal cancer, ECAN is bringing together a community of individuals and groups who are concerned about the rapid increase in esophageal cancer cases and want to support the campaign for public awareness, and the creation of more effective tools to detect and treat the disease. ECAN is dedicated to working for increased funding for medical research to battle esophageal cancer. Despite its distinction as one of the fastest increasing cancer diagnoses in the United States, esophageal cancer is currently among the most poorly funded cancers in terms of federal research dollars. ECAN and its network of supporters are working to change that. For more information, visit www.ECAN.org.
About ACMH Hospital
ACMH Hospital is an exceptional facility with a comprehensive array of services – many of which are unique for a community hospital. ACMH is becoming synonymous with innovation in community care delivery; and as such, has evolved to become a destination point of care for many throughout the region. Visit www.ACMH.org to learn more.